Due to the lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

Updates regarding government operating status and resumption of normal operations can be found at http://www.usa.gov.
NIH Human Embryonic Stem Cell Registry - Research Using These Lines is Eligible for NIH Funding

NIH Human Embryonic Stem Cell Registry
Research Using This Line is Eligible for NIH Funding

Detailed information for selected cell line:

Cell Line: WCMC-37; Fragile X mutation
NIH Registration Number: 0211
NIH Approval Number: NIHhESC-13-0211
Available for Distribution: Yes
Provider Restrictions: Available subject to a written agreement that specifies the proposed research and specific terms and conditions.

NIH Restrictions: (No Additional Restrictions)
Additional Information: Cell line carries a mutation causing Fragile X.

Submitting Organization: Joan & Sanford I. Weill Medical College of Cornell University
Provider Name: Weill Cornell Medical College- Nikica Zaninovic, PhD and Zev Rosenwaks, MD
Provider Phone: 212-746-5790
Provider Email: wcmchesc@med.cornell.edu
Provider URL: http://med.cornell.edu
Approval Date: 06/27/2013

View All Lines Eligible for Use

Go to NIH Form 2890 Login Page

Go to NIH Stem Cell Information Page

Related Resources

    NIH Form 2890:

  • Login Page
    (Authorization Required)
    Contact Us:

  • Email questions to:

  • (Emails that are offensive or unrelated to stem cells will be deleted.)

This page last updated on July 13, 2011 
Content Manager: hescregistry@mail.nih.gov 
Technical Issues: E-mail OER Webmaster